[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3436074T3 - Thiazolidforbindelser til behandling af virale infektioner - Google Patents

Thiazolidforbindelser til behandling af virale infektioner Download PDF

Info

Publication number
DK3436074T3
DK3436074T3 DK17716741.8T DK17716741T DK3436074T3 DK 3436074 T3 DK3436074 T3 DK 3436074T3 DK 17716741 T DK17716741 T DK 17716741T DK 3436074 T3 DK3436074 T3 DK 3436074T3
Authority
DK
Denmark
Prior art keywords
thiazolid
compounds
treatment
viral infections
infections
Prior art date
Application number
DK17716741.8T
Other languages
English (en)
Inventor
Jean-Francois Rossignol
Maria Gabriella Santoro
Original Assignee
Romark Laboratories Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romark Laboratories Lc filed Critical Romark Laboratories Lc
Application granted granted Critical
Publication of DK3436074T3 publication Critical patent/DK3436074T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK17716741.8T 2016-03-31 2017-03-30 Thiazolidforbindelser til behandling af virale infektioner DK3436074T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662316463P 2016-03-31 2016-03-31
PCT/US2017/024976 WO2017173056A1 (en) 2016-03-31 2017-03-30 Thiazolide compounds for treating viral infections

Publications (1)

Publication Number Publication Date
DK3436074T3 true DK3436074T3 (da) 2020-08-03

Family

ID=58530692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17716741.8T DK3436074T3 (da) 2016-03-31 2017-03-30 Thiazolidforbindelser til behandling af virale infektioner

Country Status (26)

Country Link
US (2) US11135202B2 (da)
EP (2) EP3436074B1 (da)
JP (2) JP6567781B2 (da)
KR (3) KR20210035339A (da)
CN (1) CN108289961A (da)
AU (2) AU2017244145B2 (da)
BR (1) BR112018069974A2 (da)
CA (2) CA3019326C (da)
CY (1) CY1123221T1 (da)
DK (1) DK3436074T3 (da)
EA (2) EA202091849A1 (da)
ES (1) ES2810303T3 (da)
HK (1) HK1250945A1 (da)
HR (1) HRP20201261T1 (da)
HU (1) HUE050601T2 (da)
IL (2) IL262018A (da)
LT (1) LT3436074T (da)
MX (1) MX2021004464A (da)
PH (1) PH12018502058A1 (da)
PL (1) PL3436074T3 (da)
PT (1) PT3436074T (da)
SG (1) SG11201808453UA (da)
SI (1) SI3436074T1 (da)
UA (1) UA126114C2 (da)
WO (1) WO2017173056A1 (da)
ZA (1) ZA201806644B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111012778B (zh) * 2018-10-10 2022-06-24 北京市农林科学院 Nitazoxanide在抑制犬细小病毒中的应用
CN109536460A (zh) * 2018-12-07 2019-03-29 中国医学科学院医学生物学研究所 一种cv-a10病毒毒种及其人用灭活疫苗
CN110787161B (zh) * 2019-09-19 2022-09-27 中山大学 噻唑类化合物用于抗鱼类病毒的新用途
CN111012788B (zh) * 2019-12-12 2021-01-15 武汉职业技术学院 硝唑尼特和替唑尼特在制备抗猪繁殖与呼吸综合征病毒药物中的应用
EP4182304A1 (en) 2020-07-20 2023-05-24 Romark Laboratories, L.C. Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
WO2022046622A1 (en) 2020-08-24 2022-03-03 Romark Laboratories L.C. Use of thiazolides against coronaviruses
CA3219500A1 (en) * 2021-05-28 2022-12-01 Theodore HENDERSON Treatment using an antiviral compound and nitazoxanide
WO2023040990A1 (zh) 2021-09-15 2023-03-23 南京强新生物医药有限公司 治疗冠状病毒感染的新联用药物、药物组合物及其用途
CN114404439B (zh) * 2022-02-11 2023-07-11 山东农业大学 抑制不同类型猪繁殖与呼吸综合症病毒感染的阻断剂
CN118161479A (zh) * 2024-03-12 2024-06-11 中国动物卫生与流行病学中心 银杏双黄酮在制备抗猪塞内卡病毒的制剂中的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US5387598A (en) 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5859038A (en) 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
US5856348A (en) 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
MX9604483A (es) 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US5965590A (en) 1994-09-08 1999-10-12 Romark Lab Lc Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5935591A (en) 1998-01-15 1999-08-10 Romark Laboratories, L.C. Method for treatment of equine protozoal myeloencephalitis with thiazolides
US7582297B2 (en) 2003-04-11 2009-09-01 Medimmune, Llc Methods of treating respiratory conditions
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
US20070015803A1 (en) * 2005-04-12 2007-01-18 Romark Laboratories L.C. Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
CN101448497B (zh) 2006-01-09 2013-07-10 罗马克实验室有限公司 包含硝唑尼特、替唑尼特、或其混合物的组合物在制备治疗丙型肝炎药物中的应用
ES2550755T3 (es) 2007-08-03 2015-11-12 Romark Laboratories, L.C. Compuestos de tiazolida sustituidos con alquilsulfonilo
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
EP2395840B1 (en) 2009-02-13 2020-04-15 Romark Laboratories, L.C. Controlled release pharmaceutical formulations of nitazoxanide
AU2010247816B2 (en) * 2009-05-12 2015-12-17 Romark Laboratories L.C. Haloalkyl heteroaryl benzamide compounds
AP2012006064A0 (en) 2009-06-26 2012-02-29 Romark Lab Lc Compounds and methods for treating influenza.
WO2011160191A1 (en) * 2010-06-25 2011-12-29 Biota Scientific Management Pty Ltd Compound for the treatment of enteroviruses
NZ611410A (en) 2010-11-01 2016-02-26 Romark Lab Lc Alkylsulfinyl-substituted thiazolide compounds
CA2836253C (en) 2011-05-16 2021-02-16 Romark Laboratories, L.C. Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
WO2013136495A1 (ja) 2012-03-15 2013-09-19 トヨタ自動車株式会社 車両走行制御装置
SG10201804835VA (en) * 2013-10-11 2018-07-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
WO2016044656A1 (en) * 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
EP3217795A4 (en) 2014-11-11 2018-08-22 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof

Also Published As

Publication number Publication date
UA126114C2 (uk) 2022-08-17
US20170281603A1 (en) 2017-10-05
MX2021004464A (es) 2021-06-04
JP2019203014A (ja) 2019-11-28
BR112018069974A2 (pt) 2019-01-29
EA201891975A1 (ru) 2019-03-29
LT3436074T (lt) 2020-09-25
EA202091849A1 (ru) 2020-12-11
KR20180125552A (ko) 2018-11-23
ES2810303T3 (es) 2021-03-08
IL280327A (en) 2021-03-01
CY1123221T1 (el) 2021-10-29
JP6567781B2 (ja) 2019-08-28
EA036505B1 (ru) 2020-11-18
KR102233826B1 (ko) 2021-03-31
PT3436074T (pt) 2020-08-21
KR20210035339A (ko) 2021-03-31
CA3113354A1 (en) 2017-10-05
HRP20201261T1 (hr) 2021-02-05
EP3436074B1 (en) 2020-06-10
US11135202B2 (en) 2021-10-05
SG11201808453UA (en) 2018-10-30
ZA201806644B (en) 2021-02-24
SI3436074T1 (sl) 2020-09-30
IL262018A (en) 2018-10-31
EP3677282A1 (en) 2020-07-08
CA3019326A1 (en) 2017-10-05
JP2019510044A (ja) 2019-04-11
PH12018502058A1 (en) 2019-06-24
AU2017244145A1 (en) 2018-11-15
US20220125767A1 (en) 2022-04-28
CA3019326C (en) 2021-05-25
WO2017173056A1 (en) 2017-10-05
KR20180124970A (ko) 2018-11-21
HUE050601T2 (hu) 2020-12-28
HK1250945A1 (zh) 2019-01-18
PL3436074T3 (pl) 2020-11-02
AU2019236602A1 (en) 2019-10-17
CN108289961A (zh) 2018-07-17
AU2017244145B2 (en) 2019-08-01
KR102136803B1 (ko) 2020-07-22
EP3436074A1 (en) 2019-02-06

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
DK3349758T3 (da) Fremgangsmåder til behandling af arenaviridae-virusinfektioner
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3245206T3 (da) Pyrazinforbindelser til behandling af infektionssygdomme
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3728271T3 (da) Makrocykliske forbindelser til behandling af sygdomme
DK3400291T3 (da) Manipuleret virus
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner
DK3521282T3 (da) Quinazolinderivater anvendt til behandling af hiv
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
DK3439635T3 (da) Formuleringer til behandling af fast tumor
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3504210T3 (da) 7-substituerede sulfonimidoylpurinonforbindelser til behandling og forebyggelse af virusinfektion
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3099298T3 (da) Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner
DK3524255T3 (da) Sammensætning til behandling af acne
DK3294740T3 (da) Hidtil ukendte sulfonimidoylpurinonforbindelser og derivater til behandling og profylakse af virusinfektion
DK3506904T3 (da) Behandling af demens
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3318115T3 (da) Maskine til behandling af svinegylle
DK3307267T3 (da) Behandling af multipel sklerose
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer